However, we were unable to suppress the foetal program in vivo using the FAK-inhibitor VS-471840,41 (FAKi), suggesting that mechanotransduction is not involved in the activation of YAP in our BA model (Fig. 4c). Here, YAP1 is linked to breast angiosarcoma.